MAPT and Alzheimer disease: Given that plasma CFH is a biomarker for AD progression and hyperphosphorylated tau is the major constituent of neurofibrillary tangles, a defining hallmark of the disease, these observation support the idea that CR1 plays a role in the disease process, although the mechanism by which loss of Crry gives rise to either of these affects or if the two are connected has still to be determined.